Latifa Belakhel

Latifa Belakhel

Auto-generated profile, based on publicly available information

Latifa Belakhel

Ministry of Health, Rabat, Morocco

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2024 in Monaldi Archives for Chest Disease
Verified
Journal Article
Open access
PDF file
SBSoumaya Benmaamar
Soumaya Benmaamar
BEBtissame ES-SABBAHI
Btissame ES-SABBAHI
MHMohammed Taghyioullah Haiba
Mohammed Taghyioullah Haiba
MOMohamed Omari
Mohamed Omari
IHIbtissam El Harch
Ibtissam El Harch
NTNabil Tachfouti
Nabil Tachfouti
Chronic obstructive pulmonary disease (COPD) carries an important economic burden worldwide. However, the cost of this disease in Morocco is not well explored. This study aimed to estimate the economic cost associated with COPD in Morocco and identify its determinants. A cost of illness, prevalence-based study using a bottom-up approach method, including COPD patients, was carried out in 2021-2022. The cost was estimated from a societal perspective, and the time horizon was 1 year. Data collection was performed using a questionnaire including socio-demographic, clinical data, and utilization of health care resources in 2019: hospitalization, medical tests, medications, and medical visits. Direct health cost (DHC) was estimated by multiplying the use of health services by the official prices (unit costs) published by the National Agency for Health Insurance. The indirect cost (IC) represented by labor productivity losses was calculated using the human capital method. Costs were compared according to different socio-demographic and clinical factors. We included 159 patients; 82.4% were men, 80.4% were current or former smokers, and 78.7% were categorized as “high-risk” groups (grades C–D). The DHC was estimated at $1816.6 per patient per year. Pharmaceutical and hospitalization costs represented the highest part of the total DHC (42.5% and 22.1%, respectively). The IC was estimated at $709.5±1081.3 per patient per year. DHC increased with increasing disease severity and with the number of severe exacerbations (p<0.001). Current and former smokers were more costly to the healthcare system than nonsmokers (p=0.029). IC also increased with the number of severe exacerbations (p=0.003). In this study, we showed that COPD in Morocco generates important costs for the health system, mainly related to smoking and the severity of the disease. It is therefore important to strengthen tobacco control measures in our country.

28 February 2025 in Population Medicine
Verified
Journal Article
Open access
Daoud DaoudiDaoud Daoudi
Daoud Daoudi
AMAbderrahmane Moufid
Abderrahmane Moufid
NENouriya Elghoulam
Nouriya Elghoulam
FMFatima Zahra Mouzouni
Fatima Zahra Mouzouni
LBLatifa Belakhel
Latifa Belakhel
SMSlimane Mehdad
Slimane Mehdad
Introduction: There has been a reduction in tobacco smoking worldwide except in developing countries, where progress in addressing its harms has been slow. We aimed to estimate smoking prevalence and investigate its association with obesity, hyperglycemia, high blood pressure, and dyslipidemia...

1 January 2025 in The North African Journal of Food and Nutrition Research
Verified
Journal Article
Open access
PDF file
LHLAHMAM houria
LAHMAM houria
NANabila Auajjar
Nabila Auajjar
SMSlimane Mehdad
Slimane Mehdad
BMBouchra Mekkaoui
Bouchra Mekkaoui
HBHicham El Berri
Hicham El Berri
Hassan AGUENAOUHassan AGUENAOU
Hassan AGUENAOU
Background: Hypertension constitutes a principal etiological factor in cardiovascular morbidity and premature mortality worldwide, however, the epidemiological profile of its risk determinants within the Moroccan population remains inadequately characterized. Aims: This investigation aimed to estimate the prevalence of prehypertension and hypertension and elucidate their association with various sociodemographic, behavioral, and metabolic factors among adult Moroccans. Patients and Methods: Data were derived from the inaugural nationwide cross-sectional survey on non-communicable diseases risk factors, conducted between 2017 and 2018. Data collection adhered to the World Health Organization’s STEPwise approach to surveillance (STEPS). The analytical cohort comprised 4580 adults, aged 18 years and above. Results: The observed prevalence rates for prehypertension and hypertension were 42.4% and 34.5%, respectively. Individuals aged 45 years or older demonstrated a significantly elevated propensity for both prehypertension and hypertension relative to younger cohorts. Participants with university-level education exhibited a statistically significant elevated risk of hypertension compared to those with lower educational attainment. Overweight and obese individuals presented a significantly increased risk for both prehypertension and hypertension than their non-overweight peers (Adjusted Odds Ratio [AOR] = 1.83; 95% Confidence Interval [CI]: 1.58–2.13; p < 0.001; and AOR=3.06; 95% CI: 2.60–3 .60; p < 0.001, respectively). Hyperglycemia and dyslipidemia were associated with higher odds of hypertension, albeit marginally (AOR = 1.19; 95% CI: 0.99–1.41; p = 0.055; and AOR = 1.16; 95% CI: 0.99–1.37; p = 0.069, respectively). Current tobacco smokers exhibited a significantly higher risk of hypertension than non-smokers (AOR = 1.47; 95% CI: 1.09–1.98; p = 0.013). Conclusions: The prevalence of prehypertension and hypertension was substantial within the studied population. Advanced age, elevated educational attainment, obesity, hyperglycemia, dyslipidemia, and tobacco smoking were associated with an elevated risk of both prehypertension and hypertension. Consequently, the implementation of urgent public health interventions is imperative to address the health burden associated with hypertension and to prevent the progression of prehypertension to hypertension and subsequent cardiovascular diseases. Keywords: Age, Dyslipidemia, Education level, Hyperglycemia, Hypertension, Obesity, Overweight, Prehypertension.